These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Dopamine transporter in vitro binding and in vivo imaging in the brain. Bergström KA; Tupala E; Tiihonen J Pharmacol Toxicol; 2001 Jun; 88(6):287-93. PubMed ID: 11453367 [TBL] [Abstract][Full Text] [Related]
46. Discovery of drugs to treat cocaine dependence: behavioral and neurochemical effects of atypical dopamine transport inhibitors. Tanda G; Newman AH; Katz JL Adv Pharmacol; 2009; 57():253-89. PubMed ID: 20230764 [TBL] [Abstract][Full Text] [Related]
47. 2,3-Disubstituted quinuclidines as a novel class of dopamine transporter inhibitors. Sakamuri S; Enyedy IJ; Zaman WA; Tella SR; Kozikowski AP; Flippen-Anderson JL; Farkas T; Johnson KM; Wang S Bioorg Med Chem; 2003 Mar; 11(6):1123-36. PubMed ID: 12614900 [TBL] [Abstract][Full Text] [Related]
48. Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter. Reith ME; Blough BE; Hong WC; Jones KT; Schmitt KC; Baumann MH; Partilla JS; Rothman RB; Katz JL Drug Alcohol Depend; 2015 Feb; 147():1-19. PubMed ID: 25548026 [TBL] [Abstract][Full Text] [Related]
49. Cocaine abuse: hard knocks for the dopamine hypothesis? Caine SB Nat Neurosci; 1998 Jun; 1(2):90-2. PubMed ID: 10195118 [No Abstract] [Full Text] [Related]
50. Relations between heterogeneity of dopamine transporter binding and function and the behavioral pharmacology of cocaine. Katz JL; Newman AH; Izenwasser S Pharmacol Biochem Behav; 1997 Jul; 57(3):505-12. PubMed ID: 9218275 [TBL] [Abstract][Full Text] [Related]
51. Psychostimulant drugs and a dopamine hypothesis regarding addiction: update on recent research. Ritz MC; Kuhar MJ Biochem Soc Symp; 1993; 59():51-64. PubMed ID: 7910741 [TBL] [Abstract][Full Text] [Related]
52. [3-cis-3,5-Dimethyl-(1-piperazinyl)alkyl]-bis-(4'-fluorophenyl)amine analogues as novel probes for the dopamine transporter. Cao J; Husbands SM; Kopajtic T; Katz JL; Newman AH Bioorg Med Chem Lett; 2001 Dec; 11(24):3169-73. PubMed ID: 11720867 [TBL] [Abstract][Full Text] [Related]
53. Role of serotonin in cocaine effects in mice with reduced dopamine transporter function. Mateo Y; Budygin EA; John CE; Jones SR Proc Natl Acad Sci U S A; 2004 Jan; 101(1):372-7. PubMed ID: 14691264 [TBL] [Abstract][Full Text] [Related]
55. Pharmacodynamic assessment of the benztropine analogues AHN-1055 and AHN-2005 using intracerebral microdialysis to evaluate brain dopamine levels and pharmacokinetic/pharmacodynamic modeling. Raje S; Cornish J; Newman AH; Cao J; Katz JL; Eddington ND Pharm Res; 2005 Apr; 22(4):603-12. PubMed ID: 15846468 [TBL] [Abstract][Full Text] [Related]
56. Dopamine reuptake transporter (DAT) "inverse agonism"--a novel hypothesis to explain the enigmatic pharmacology of cocaine. Heal DJ; Gosden J; Smith SL Neuropharmacology; 2014 Dec; 87():19-40. PubMed ID: 24953830 [TBL] [Abstract][Full Text] [Related]
57. N-substituted benztropine analogs: selective dopamine transporter ligands with a fast onset of action and minimal cocaine-like behavioral effects. Li SM; Kopajtic TA; O'Callaghan MJ; Agoston GE; Cao J; Newman AH; Katz JL J Pharmacol Exp Ther; 2011 Feb; 336(2):575-85. PubMed ID: 21088247 [TBL] [Abstract][Full Text] [Related]
58. Structure-Activity Relationship Studies on a Series of 3α-[Bis(4-fluorophenyl)methoxy]tropanes and 3α-[Bis(4-fluorophenyl)methylamino]tropanes As Novel Atypical Dopamine Transporter (DAT) Inhibitors for the Treatment of Cocaine Use Disorders. Zou MF; Cao J; Abramyan AM; Kopajtic T; Zanettini C; Guthrie DA; Rais R; Slusher BS; Shi L; Loland CJ; Newman AH J Med Chem; 2017 Dec; 60(24):10172-10187. PubMed ID: 29227643 [TBL] [Abstract][Full Text] [Related]
59. Effects of two-carbon bridge region methoxylation of benztropine: discovery of novel chiral ligands for the dopamine transporter. Simoni D; Roberti M; Rondanin R; Baruchello R; Rossi M; Invidiata FP; Merighi S; Varani K; Gessi S; Borea PA; Marino S; Cavallini S; Bianchi C; Siniscalchi A Bioorg Med Chem Lett; 2001 Mar; 11(6):823-7. PubMed ID: 11277529 [TBL] [Abstract][Full Text] [Related]
60. Design and synthesis of an irreversible dopamine-sparing cocaine antagonist. Meltzer PC; Liu S; Blanchette H; Blundell P; Madras BK Bioorg Med Chem; 2002 Nov; 10(11):3583-91. PubMed ID: 12213473 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]